MARAVAI LIFESCIENCES HLDGS-A (MRVI)
US56600D1072 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to MRVI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.41. This target is 118.52% above the current price.
MRVI was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MRVI.
In the previous month the buy percentage consensus was at a similar level.
MRVI was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-14 | Wolfe Research | Initiate | Peer Perform |
| 2024-11-08 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-11-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-08-27 | Wells Fargo | Initiate | Overweight |
| 2024-08-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-13 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-07-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-09 | Baird | Maintains | Outperform -> Outperform |
| 2024-04-10 | Craig-Hallum | Initiate | Buy |
| 2024-02-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-23 | Stifel | Maintains | Buy -> Buy |
| 2023-12-12 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-11-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-08 | Deutsche Bank | Maintains | Buy -> Buy |
| 2023-08-08 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2023-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-08 | Baird | Maintains | Outperform -> Outperform |
| 2023-08-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-08 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-05-23 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-05-10 | Goldman Sachs | Maintains | Neutral |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-05-09 | Deutsche Bank | Maintains | Buy |
| 2023-05-09 | RBC Capital | Maintains | Outperform |